Headquarters
225 MYSTIC VALLEY PKWY, WINCHESTER, MA 01890-3130, US
WINCHESTER, MA, US
AQUILUS PHARMACEUTICALS INC
From the company
Aquilus Pharmaceuticals is a Pre-series A biotech dedicated to developing a first-in-class medication for neurodegenerative diseases, with a primary focus on Amyotrophic Lateral Sclerosis (ALS). It has been funded via the ALS Association, NIH, and Department of Defense grants in developing a new therapeutic (AQU-118) to treat ALS. The company has completed IND enabling studies for AQU-118 and is on track toward a phase I trial in the first quarter of 2026.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.